Recall Register

Drug recall: Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014…

Class II FDA enforcement event 100087. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Failed dissolution specifications

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

STRIDES PHARMA INC started this drug recall on 7 Oct 2026. The firm address in the FDA record is in Bridgewater, NJ. FDA put the recall in Class II. FDA event 100087 has 1 product record. The first FDA enforcement report date is 28 Oct 2026. The record gives the status Ongoing. 75 of the 268 drug events that started in 2026 have more product records. The median drug event of 2026 has 1 product record.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide

Recalling firm

STRIDES PHARMA INC, Bridgewater, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 100087: product records
Recall numberProductQuantityClassStatusReport date
D-0079-2027Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-0449,488 30-count bottlesClass IIOngoing28 Oct 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2026
268
Share of these events in Class II
75%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
11

Other events of the firm

Other FDA enforcement events of STRIDES PHARMA INC
InitiatedProduct (first record)TypeClassRecords
2 Mar 2026Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro PharmaceuticaDrugClass II1
9 Jul 2025Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, India; DisDrugClass II1
5 Mar 2025Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East BruDrugClass II2
29 Dec 2023Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 56210DrugClass II1
26 Jun 2023Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life ScieDrugClass II1
19 Jul 2022Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 5621DrugClass II1
18 May 2022Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 1DrugClass II3
27 Sep 2021Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun DrugClass II1
22 Dec 2020NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. BengalurDrugClass III1
9 May 2017Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 IndiaDrugClass III1

STRIDES PHARMA INC: all 11 events

Official channels

Cite this page

Recall Register. FDA enforcement event 100087. https://recallregister.com/fda/ii/100087/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
3 Nov 2026
Newest FDA report date on the register
28 Oct 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide
What quantity of product is in FDA event 100087?
The FDA record gives this quantity: 49,488 30-count bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2026 have the same class?
75% of the 268 drug events that started in 2026 are in Class II.